TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SPRB

Spruce Biosciences, Inc.

Healthcare · Biotechnology

48.70$ -0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Spruce Biosciences, Inc. (SPRB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow SPRB
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-8.6 -13 -28 -36 -42 -33 -56 -33
0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0
0.1 0.2 0.8 4.0 3.6 4.6 5.3 2.6
0.1 0.2 0.8 4.4 3.7 – – –
1.2 0.3 1.2 2.0 1.1 10 -8.6 -0.7
0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0
0.0 0.0 -0.1 -79 24 56 – –
– – – 0.4 – 0.2 – –
– – 93 0.1 0.0 -0.3 0.1 0.0
4.5 4.5 0.2 0.2 0.0 -1.6 -1.6 -2.1
12 12 181 0.6 -0.2 49 -1.6 43
-8.6 -0.2 153 -114 -18 72 -58 10
-8.6 -13 -28 -36 -42 -33 -56 -33

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?